# STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

> **NCT04973423** · NA · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 180 (estimated)

## Conditions studied

- Crohn Disease
- Calprotectin
- MRI

## Interventions

- **RADIATION:** MRI

## Key facts

- **NCT ID:** NCT04973423
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-21
- **Primary completion:** 2027-03-21
- **Final completion:** 2027-08-21
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973423, "STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT04973423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*